Albemarle Corporation  

(Public, NYSE:ALB)   Watch this stock  
108.06
+1.23 (1.15%)
Real-time:   10:56AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 107.37 - 108.32
52 week 65.57 - 108.32
Open 107.44
Vol / Avg. 221,406.00/908,403.00
Mkt cap 12.16B
P/E 27.58
Div/yield 0.32/1.18
EPS 3.92
Shares 112.57M
Beta 1.47
Inst. own 90%
May 12, 2017
Albemarle Corp Annual Shareholders Meeting - 7:00AM EDT - Add to calendar
May 4, 2017
Q1 2017 Albemarle Corp Earnings Call - 9:00AM EDT - Add to calendar
May 3, 2017
Q1 2017 Albemarle Corp Earnings Release - 4:00PM EDT - Add to calendar
Mar 16, 2017
Albemarle Corp Investor Day - Webcast
Feb 28, 2017
Q4 2016 Albemarle Corp Earnings Call - Webcast
Feb 27, 2017
Q4 2016 Albemarle Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 5.09% 15.65%
Operating margin 11.96% 21.46%
EBITD margin - 27.74%
Return on average assets 1.62% 4.72%
Return on average equity 4.76% 12.53%
Employees 5,000 -
CDP Score - -

Address

4350 Congress St Ste 700
CHARLOTTE, NC 28209-4865
United States - Map
+1-980-2995700 (Phone)
+1-225-3887686 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions. The bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Company serves various end markets, including petroleum refining, consumer electronics, energy storage, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety and custom chemistry services. As of December 31, 2016, the Company and its joint ventures operated 31 production and research and development (R&D) facilities, as well as a number of administrative and sales offices, around the world.

Officers and directors

Luther C. Kissam IV President, Chief Executive Officer, Principal Financial Officer, Director
Age: 51
Bio & Compensation  - Reuters
Karen G. Narwold Executive Vice President, Chief Administrative Officer
Age: 56
Bio & Compensation  - Reuters
Matthew K. Juneau Senior Vice President - Corporate Strategy and Investor Relations
Age: 55
Bio & Compensation  - Reuters
Donald J. LaBauve Jr. Chief Accounting Officer, Vice President, Corporate Controller
Age: 49
Bio & Compensation  - Reuters
David Ryan Treasurer
Bio & Compensation  - Reuters
Jimmy W. Nokes Independent Non-Executive Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
William H. Hernandez Independent Director
Age: 68
Bio & Compensation  - Reuters
Douglas L. Maine Independent Director
Age: 68
Bio & Compensation  - Reuters
Jerry Kent Masters Independent Director
Age: 57
Bio & Compensation  - Reuters
James J. O'Brien Independent Director
Age: 62
Bio & Compensation  - Reuters